These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 9252380)
1. Generation of angiostatin by reduction and proteolysis of plasmin. Catalysis by a plasmin reductase secreted by cultured cells. Stathakis P; Fitzgerald M; Matthias LJ; Chesterman CN; Hogg PJ J Biol Chem; 1997 Aug; 272(33):20641-5. PubMed ID: 9252380 [TBL] [Abstract][Full Text] [Related]
2. Angiostatin formation involves disulfide bond reduction and proteolysis in kringle 5 of plasmin. Stathakis P; Lay AJ; Fitzgerald M; Schlieker C; Matthias LJ; Hogg PJ J Biol Chem; 1999 Mar; 274(13):8910-6. PubMed ID: 10085135 [TBL] [Abstract][Full Text] [Related]
3. Characterization of a reduced form of plasma plasminogen as the precursor for angiostatin formation. Butera D; Wind T; Lay AJ; Beck J; Castellino FJ; Hogg PJ J Biol Chem; 2014 Jan; 289(5):2992-3000. PubMed ID: 24338014 [TBL] [Abstract][Full Text] [Related]
4. Macrophage formation of angiostatin during inflammation. A byproduct of the activation of plasminogen. Falcone DJ; Khan KM; Layne T; Fernandes L J Biol Chem; 1998 Nov; 273(47):31480-5. PubMed ID: 9813061 [TBL] [Abstract][Full Text] [Related]
5. Different inhibitors of plasmin differentially affect angiostatin production and angiogenesis. Hatziapostolou M; Katsoris P; Papadimitriou E Eur J Pharmacol; 2003 Jan; 460(1):1-8. PubMed ID: 12535853 [TBL] [Abstract][Full Text] [Related]
6. Human prostate carcinoma cells express enzymatic activity that converts human plasminogen to the angiogenesis inhibitor, angiostatin. Gately S; Twardowski P; Stack MS; Patrick M; Boggio L; Cundiff DL; Schnaper HW; Madison L; Volpert O; Bouck N; Enghild J; Kwaan HC; Soff GA Cancer Res; 1996 Nov; 56(21):4887-90. PubMed ID: 8895739 [TBL] [Abstract][Full Text] [Related]
7. Plasmin-induced migration of endothelial cells. A potential target for the anti-angiogenic action of angiostatin. Tarui T; Majumdar M; Miles LA; Ruf W; Takada Y J Biol Chem; 2002 Sep; 277(37):33564-70. PubMed ID: 12087108 [TBL] [Abstract][Full Text] [Related]
8. Transforming growth factor-beta 1 inhibits generation of angiostatin by human pancreatic cancer cells. O'Mahony CA; Albo D; Tuszynski GP; Berger DH Surgery; 1998 Aug; 124(2):388-93. PubMed ID: 9706163 [TBL] [Abstract][Full Text] [Related]
9. Biological regulation through protein disulfide bond cleavage. Hogg PJ Redox Rep; 2002; 7(2):71-7. PubMed ID: 12189052 [TBL] [Abstract][Full Text] [Related]
14. Purification and characterization of A61. An angiostatin-like plasminogen fragment produced by plasmin autodigestion in the absence of sulfhydryl donors. Kassam G; Kwon M; Yoon CS; Graham KS; Young MK; Gluck S; Waisman DM J Biol Chem; 2001 Mar; 276(12):8924-33. PubMed ID: 11114303 [TBL] [Abstract][Full Text] [Related]
16. Suppression of angiogenesis and tumor growth by the inhibitor K1-5 generated by plasmin-mediated proteolysis. Cao R; Wu HL; Veitonmäki N; Linden P; Farnebo J; Shi GY; Cao Y Proc Natl Acad Sci U S A; 1999 May; 96(10):5728-33. PubMed ID: 10318952 [TBL] [Abstract][Full Text] [Related]